Corneal Edema Treatment Market Outlook, Segments Share Analysis, Market Scenario Forecast 2019-2029
VALLEY COTTAGE, N.Y. – Corneal edema is refer to a cornea that is excessively hydrated than the normal 78% water content. Excess hydration of cornea causes to loss transparency of cornea and leads to impaired vision and eye pain. The corneal edema treatment choice is depends on the specific cause and related symptoms of an individual patient. Elimination of the underlying aetiology must be targeted in the case of secondary edema (inflammation, infection, trauma, glaucoma). Topical corticosteroids and hypertonic agent are considered to be primary treatment therapies.
Topical corticosteroids reduces anterior segment inflammation and consequently corneal edema. Other complications is increase in intraocular pressure, which can be treated using hypertonic agent, carbonic anhydrase inhibitors. Antibiotic therapies can be preferred in case of infection based corneal edema.
Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10832
For management of primary corneal edema, hypertonic agent in the form of topical drops and ointment can be prefer to treat mild edema which draw out excessive corneal fluid. In addition, bandage contact lens on cornea can be used as an auxiliary treatments to provide relief from discomfort of edema when surgical intervention is not recommended or is delayed. In case of high-risk chronic corneal edema, surgical corneal transplantation treatment can be performed to improve vision of the patient.
Corneal Edema Treatment Market: Drivers and Restraints
Corneal edema treatment market is expected to witness high growth owing to increasing aging population and rise in eye disease prevalence. From patient perspective, increasing clinical research and subsequent new product launch is expected to fuel the corneal edema treatment market. Increasing number of corneal trauma from cataract surgeries and accidents is a major driving factor of corneal edema treatment market. However, low healthcare expenditure are expected to hamper the future corneal edema treatment market in developing economies. Also, less awareness among the patient about the treatment option may deter the progress of corneal edema treatment market.
Preview Analysis of Corneal Edema Treatment Market – Global Industry Analysis 2014 – 2018 and Opportunity Assessment; 2019 – 2029: https://www.futuremarketinsights.com/reports/corneal-edema-treatment-market
Corneal Edema Treatment Market: Overview
The global corneal edema treatment market is estimated to grow steady growth over forecast years owing to global rise in aging populations, increasing number of surgical procedures associated with eye disease epidemic. According to WHO, glaucoma is second leading cause of blindness globally which needs corneal edema prone surgical procedures. In corneal treatment market, topical corticosteroids and hypertonic agents therapies are expected to grow with high rate owing to their use in first-line treatment in acute as well chronic conditions of corneal edema. Recently, DEXTENZA, a dexamethasone corticosteroid containing advanced delivery ophthalmic insert manufactured by Ocular Therapeutics is approved by US FDA. However, corneal devices and transplantations associated post use/surgery risk is hampering their preference in treatment options.
Corneal Edema Treatment Market: Regional Outlook
The global corneal edema treatment market is expected to be dominated by North America due to higher product research and development activities with existing product availability. Europe is expected to be the second most growing region in the global corneal edema treatment market owing to advancements in early diagnosis and treatment. Latin America is emerging region for corneal edema treatment market and is estimated to show exponential growth owing to high product availability.
Buy this report @ https://www.futuremarketinsights.com/checkout/10832
East-Asia corneal edema treatment market is expected to show significant growth as high prevalence. Middle East & Africa is expected to be the least lucrative region in the corneal edema treatment market due to least product adoption and standard diagnosis and treatment seeking rate.
Corneal Edema Treatment Market: Key Players
The key players operating in the global corneal edema treatment market are: Pfizer Inc., Abbvie Inc, Novartis, Hoffmann-La Roche Ltd., Allergan, Bayer AG, Bausch & Lomb Incorporated, Johnson & Johnson, Teva Pharmaceuticals, Sun Pharmaceutical and others.
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-10832
- Dental X Ray Systems Market
- Over The Counter Pain Medication Market
- Seasonal Affective Disorder Therapeutics Market
Future Market Insights (FMI) is a leading market intelligence and
consulting firm. We deliver syndicated research reports, custom research
reports and consulting services which are personalized in nature. FMI delivers
a complete packaged solution, which combines current market intelligence,
statistical anecdotes, technology inputs, valuable growth insights and an
aerial view of the competitive framework and future market trends.Contact Us
Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
T (UK): + 44-(0)-20-7692-8790
Press Office: Press@futuremarketinsights.com
Blog: Market Research Blog